Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate

Published

Specializes in Critical care, tele, Medical-Surgical.

The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH

“The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want to assure the American people that the FDA’s process and evaluation of the data for a potential COVID-19 vaccine will be as open and transparent as possible,” said FDA Commissioner Stephen M. Hahn, M.D....

...   The FDA intends to make background materials available to the public, including the meeting agenda and committee roster, no later than two business days prior to the meeting....

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-announces-advisory-committee-meeting-discuss-covid-19-vaccine

 

4
Up Vote Up Vote ×
Specializes in Critical care, tele, Medical-Surgical.

Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement

Agenda: The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older.

Meeting Materials: FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting, any background material will be made publicly available at the time of the advisory committee meeting, and additional materials will be posted on FDA's website after the meeting...

Please note that due to the impact of this COVID-19 pandemic, all meeting participants will be joining this advisory committee meeting via an online teleconferencing platform.

The online web conference meeting will be available at the following: 
https://youtu.be/owveMJBTc2IExternal Link Disclaimer 
https://Twitter.com/US_FDAExternal Link Disclaimer (Supported in Chrome browser)
https://fda.yorkcast.com/webcast/Play/d75d80a3eb6e419986181c1a881fe2671dExternal Link Disclaimer.

https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-december-10-2020-meeting-announcement#event-materials

3
Up Vote Up Vote ×
Specializes in Critical care, tele, Medical-Surgical.

Just a reminder that the FDA "Vaccines and Related Biological Products Advisory Committee" is being broadcast now. I plan to watch off and on here:  

 

Here are the Event Materials 

https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-december-10-2020-meeting-announcement#event-materials 

3
Up Vote Up Vote ×
Specializes in Critical Care; Cardiac; Professional Development.

I underwent training yesterday on administration of the vaccine and we have gotten the priority schedule for being able to get it. Continued reiteration that nobody is required to take it. 

I have decided I am comfortable with it. 

2
Up Vote Up Vote ×
+ Join the Discussion